Predictive and prognostic role of fragile histidine triad (FHIT) and P53 gene inactivaton in non-small-cell lung cancer (NSCLC) patients treated with platinum-analogue regimen

被引：0
|
作者：
Cortinovis, D.
Bajetta, E.
Sozzi, G.
Mariani, L.
Fabbri, A.
Livio, A.
Roz, L.
Andriani, F.
Perego, P.
Zilembo, N.
Formisano, B.
Bidoli, P.
机构：
[1] Ist Nazl Studio & Cura Tumori, Med Oncol Unit 2, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Studio & Cura Tumori, Dept Med Stat, I-20133 Milan, Italy
[4] Ist Nazl Studio & Cura Tumori, Anat Pathol Unit, I-20133 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI19 / XI19
页数：1
相关论文
共 50 条
  • [21] p53 tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy
    Junker, K
    Wiethege, T
    Müller, KM
    Thomas, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (04) : 238 - 245
  • [22] K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
    Y Fukuyama
    T Mitsudomi
    K Sugio
    T Ishida
    K Akazawa
    K Sugimachi
    British Journal of Cancer, 1997, 75 : 1125 - 1130
  • [23] K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
    Fukuyama, Y
    Mitsudomi, T
    Sugio, K
    Ishida, T
    Akazawa, K
    Sugimachi, K
    BRITISH JOURNAL OF CANCER, 1997, 75 (08) : 1125 - 1130
  • [24] p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
    FJ Vega
    P Iniesta
    T Caldés
    A Sánchez
    JA López
    C de Juan
    E Diaz-Rubio
    A Torres
    JL Balibrea
    M Benito
    British Journal of Cancer, 1997, 76 : 44 - 51
  • [25] p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
    Vega, FJ
    Iniesta, P
    Caldes, T
    Sanchez, A
    Lopez, JA
    deJuan, C
    DiazRubio, E
    Torres, A
    Balibrea, JL
    Benito, M
    BRITISH JOURNAL OF CANCER, 1997, 76 (01) : 44 - 51
  • [26] P53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel
    Yumuk, R
    Turhal, N
    Ahiskali, R
    Gumus, M
    Hatabay, N
    Turken, O
    Ozkan, A
    Salepci, T
    Aliustaoglu, M
    LUNG CANCER, 2005, 49 : S152 - S152
  • [27] p53 polymorphisms predict poor clinical outcome in non-small-cell lung cancer patients treated with radiotherapy/chemotherapy
    Rohatgi, P. R.
    Chang, J. Y.
    Spitz, M. R.
    Liu, J.
    Lu, C.
    Stewart, D.
    Allen, P. K.
    Cox, J. D.
    Komaki, R.
    Wu, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S156 - S156
  • [28] The predictive value of clinical variables in patients affected with non-small-cell lung cancer (NSCLC) treated with pemetrexed (PEM) plus platinum-based regimen: A retrospective analysis.
    Fabbri, Maria Agnese
    Moscetti, Luca
    Nelli, Fabrizio
    Gamucci, Teresa
    Mansueto, Giovanni
    Narducci, Filomena
    Quadrini, Silvia
    Sperduti, Isabella
    Passaro, Antonio
    Campenni, Giuseppe
    Cortesi, Enrico
    Martelli, Olga
    Bianchetti, Sara
    Angelini, Francesco
    Pellegrino, Arianna
    Pavese, Ida
    Signorelli, Carlo
    Ruggeri, Enzo Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Prognostic and Predictive Role of KRAS-Mutations in Patients with Advanced Non-Squmous Non-Small-Cell Lung Cancer (NS-NSCLC)
    Sanchez-Salinas, Mario A.
    Garde-Noguera, Javier
    Sanchez, Jose Garcia
    Valera, Marisol
    Marin, Sara
    Hidalgo, Julia
    Arturo Albino, Rene
    Ferrando Marco, Jose
    Llombart Cussac, Antonio
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S454 - S454
  • [30] Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
    Nemunaitis, J
    Swisher, SG
    Timmons, T
    Connors, D
    Mack, M
    Doerksen, L
    Weill, D
    Wait, J
    Lawrence, DD
    Kemp, BL
    Fossella, F
    Glisson, BS
    Hong, WK
    Khuri, FR
    Kurie, JM
    Lee, JJ
    Lee, JS
    Nguyen, DM
    Nesbitt, JC
    Perez-Soler, R
    Pisters, KMW
    Putnam, JB
    Richli, WR
    Shin, DM
    Walsh, GL
    Merritt, J
    Roth, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 609 - 622
12345